Accompanied by checklist, question form, and 2 strategy cards in pocket, p. [3] of cover.

Clinical Psychopharmacology offers a comprehensive guide to clinical practice that explores two major aspects of the field: the clinical research that exists to guide clinical practice of psychopharmacology, and the application of that knowledge with attention to the individualized aspects of clinical practice. The text consists of 50 chapters, organized into 6 sections, focusing on disease-modifying effects, non-DSM diagnostic concepts, and essential facts about the most common drugs. This innovative book advocates a scientific and humanistic approach to practice and examines not only the benefits, but also the harms of drugs. Providing a solid foundation of knowledge and a great deal of practical information, this book is a valuable resource for practicing psychiatrists, psychiatric nurse practitioners, medical students and trainees in psychiatry, as well as pharmacists.

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

A practical guide translating clinical trials findings, across major psychiatric disorders, to devise tailored, evidence-based treatments.

"The 2nd edition of this book was edited by David King and published in 2004. Since then there have been major advances in psychopharmacology in terms of new medications coming to the market, increased understanding of the mechanisms of drug action and new data on the efficacy, tolerability, safety and clinical effectiveness of a range of medications. Partly as a result, clinical guidelines for many psychiatric disorders have altered. As such, a new edition of this textbook was essential and we were delighted when the College approached us to edit the 3rd edition. This was a major endeavor that was only possible with the commitment and expertise of the authors"--

David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory. But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize. Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.

Our remedies are only as good as the way in which we dispense them. That is the central premise of Thinking About Prescribing. In this new, thought-provoking volume, more than two dozen experts make the case for an ongoing alliance between pharmacotherapists, young patients, and their families. Chapters tackle issues ranging from the psychodynamics of medication use in youth with serious mental illness, adapting evidence-based motivation and therapy techniques to enhance adherence, cultivating the synergistic role of primary care providers and psychotherapists, engaging in psychoeducation with patients, to prescribing via telemedicine. Readers will pick up the foundational knowledge they need to develop a partnership with patients that is based on trust and candid communication--rather than on just the cold facts about psychotropic medications. Chapters feature key takeaways that distill the most salient points, helping readers to reference--and retain--the information easily.

TABLE OF CONTENTS: 1 General Principles. 2 Depression. 3 Bipolar Illness. 4 Anxiety Disorders. 5 Psychotic Disorders. 6 Miscellaneous Disorders. 7 non-Response and "Breakthrough Symptoms" Algorithms. 8 Case Examples. App. A- History and personal Data Questionnaire. App. B- Special Cautions When Taking MAO Inhibitors.

A spin-off of the best-selling Stahl's Prescriber's Guide, covering the most important drugs for treating patients with psychotic illness.

This is a 2016 pocket guide of psychiatric medications. It functions as a quick resource for health care professionals and students whom have involvement with psychiatric patients and their medications. It serves to give the clinician a foothold in an environment that differs from other experiences in medicine, with unique terminology and disease states. This reference covers the core medications used in general psychiatry practice from a pharmaceutical standpoint. The handbook begins with a brief introduction of terminology and psychiatric legal parameters, to medication doses, black box warnings, side effects, drug interactions, and most importantly, monitoring parameters. Also included is a simple guide to make pharmaceutical interventions on patients' drug therapy. Disease states such as Anxiety, Attention Deficit Hyperactivity Disorder, Bipolar Disorder, Major Depression, Geropsychiatry, Pregnancy and Lactation, Schizophrenia, Seizure Disorders, Substance Abuse, and many more are reviewed. Best of all, the most important information for each is provided in summative, and easily indexed formats, so you can find the information you need as rapidly as you need it. This could be the best quick reference for important psychopharmacologic information you'll ever own.